Analysis: Danaher Corporation

US:DHR

Why is Danaher Corporation stock rising?

  • Startup of Pall's new Singapore plant to support semiconductor filtration demand
  • Cytiva greenfield bioprocessing capex pipeline expected to convert over the next two to three years
  • Cepheid Multiplex GI panel key account wins with large hospital networks
  • DxI 9000 blood-virus menu completion enabling accelerated Beckman placements and customer wins
  • FY2026 adjusted EPS guidance raise

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Danaher Corporation and 4,900+ companies.

Sign in
5-day free pass. No card required.